Agenda:
- Discussion on the design and outcomes of three clinical trials involving Supraflex Cruz DES : RCTs – Tuxedo-II, Multivessel Talent, and Registry – Cruz Senior.
FACULTY
![]() |
Patrick W Serruys, MD, PhD |
![]() |
Sripal Bangalore, MD, MHA |
![]() |
David M. Leistner, MD |



